Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues

被引:86
作者
Estes, Jacob D. [1 ]
机构
[1] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
T cells; AIDS; lymph nodes; inflammation; fibrosis;
D O I
10.1111/imr.12070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acquired immunodeficiency syndrome (AIDS) is principally a disease of lymphoid tissues (LTs), due to the fact that the main target cell of human immunodeficiency virus (HIV) is the CD4+ T lymphocyte that primarily resides within organs of the immune system. The impact of HIV infection on secondary LTs, in particular lymph nodes, is critical to delineate, as these immune organs are the principal sites for initiating and facilitating immune responses and are critical for lymphocyte homeostatic maintenance and survival. The underlying structural elements of LTs, fibroblastic reticular cell (FRC) network, not only form the architectural framework for these organs, but also play in integral role in the production and storage of cytokines needed for T-cell survival. There is an interdependent relationship between the FRC stromal network and CD4+ T lymphocytes for their survival and maintenance that is progressively disrupted during HIV disease. HIV infection results in profound pathological changes to LTs induced by persistent chronic immune activation and inflammation that leads to progressive collagen deposition and fibrosis disrupting and damaging the important FRC network. In this review, I focus on the process, mechanisms, and the implications of pathological damage to important secondary LTs, combining what we have learned from HIV-infected individuals as well as the invaluable knowledge gained from studies in non-human primate simian immunodeficiency virus infection models.
引用
收藏
页码:65 / 77
页数:13
相关论文
共 114 条
  • [11] B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement
    Bleul, CC
    Schultze, JL
    Springer, TA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) : 753 - 762
  • [12] TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR
    BORDER, WA
    RUOSLAHTI, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 1 - 7
  • [13] BORDER WA, 1994, NEW ENGL J MED, V331, P1286
  • [14] Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys
    Bosinger, Steven E.
    Li, Qingsheng
    Gordon, Shari N.
    Klatt, Nichole R.
    Duan, Lijie
    Xu, Luoling
    Francella, Nicholas
    Sidahmed, Abubaker
    Smith, Anthony J.
    Cramer, Elizabeth M.
    Zeng, Ming
    Masopust, David
    Carlis, John V.
    Ran, Longsi
    Vanderford, Thomas H.
    Paiardini, Mirko
    Isett, R. Benjamin
    Baldwin, Don A.
    Else, James G.
    Staprans, Silvija I.
    Silvestri, Guido
    Haase, Ashley T.
    Kelvin, David J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (12) : 3556 - 3572
  • [15] Microbial translocation is a cause of systemic immune activation in chronic HIV infection
    Brenchley, Jason M.
    Price, David A.
    Schacker, Timothy W.
    Asher, Tedi E.
    Silvestri, Guido
    Rao, Srinivas
    Kazzaz, Zachary
    Bornstein, Ethan
    Lambotte, Olivier
    Altmann, Daniel
    Blazar, Bruce R.
    Rodriguez, Benigno
    Teixeira-Johnson, Leia
    Landay, Alan
    Martin, Jeffrey N.
    Hecht, Frederick M.
    Picker, Louis J.
    Lederman, Michael M.
    Deeks, Steven G.
    Douek, Daniel C.
    [J]. NATURE MEDICINE, 2006, 12 (12) : 1365 - 1371
  • [16] Microbial Translocation Across the GI Tract
    Brenchley, Jason M.
    Douek, Daniel C.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 : 149 - 173
  • [17] The mucosal barrier and immune activation in HIV pathogenesis
    Brenchley, Jason M.
    Douek, Daniel C.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2008, 3 (03) : 356 - 361
  • [18] BURTON GF, 1993, J IMMUNOL, V150, P31
  • [19] Lymphocyte homing and homeostasis
    Butcher, EC
    Picker, LJ
    [J]. SCIENCE, 1996, 272 (5258) : 60 - 66
  • [20] CAMERON PU, 1987, CLIN EXP IMMUNOL, V68, P465